$MTHRY – M3, Inc.

$MTHRY – M3, Inc.

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates m3.com, a members-only Web site for providing information to the healthcare professionals; and MR-kun that delivers medical and drug information online through m3.com. It also provides MDLinx that offers the review of medical articles and theses in English for physicians in the United States; and MEDI:GATE, which provides various medical news and content, and features online discussion boards where doctors can exchange opinions and communicate with one another in South Korea. In addition, the company offers various Internet-based services for pharmaceutical and other medical-related companies, including marketing support services for medical solution providers and healthcare professionals, clinical trial services, clinical trial support services, market research services, and doctor and pharmacist recruiting support services. Further, it provides services for general public, such as the operation of AskDoctors, a Q and A site to consult doctors through the Internet; Ichie Websites comprising Ichie Breast Cancer and Ichie Menopause, which offers insights and solutions related to breast cancer and menopause; and iTicket Plus, a reservation system for clinics through mobile phones and the Internet. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was founded in 2000 and is headquartered in Tokyo, Japan.

We only have boring company information here and no due diligence reported by users as of today.
Got an intel to share with us?

Last Updated on September 7, 2020

Disclaimer: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may/may not own the stocks they discuss. The information and content are subject to change without notice.

User Intels Reported (0)

Subscribe
Notify of
Inline Feedbacks
View all Intels